Literature DB >> 8031068

Effect of antacids in didanosine tablet on bioavailability of isoniazid.

K Gallicano1, J Sahai, G Zaror-Behrens, A Pakuts.   

Abstract

The antacids in two didanosine placebo tablets had no significant effect on the plasma pharmacokinetics of a single oral dose of 300 mg of isoniazid administered to 12 healthy volunteers. These results suggest that isoniazid bioavailability will be unaffected by the antacids in didanosine tablets when the two medications are administered simultaneously to human immunodeficiency virus-seropositive patients.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8031068      PMCID： PMC284565          DOI： 10.1128/AAC.38.4.894

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Bioavailability of three isoniazid formulations.

Authors:  S Sved; I J McGilveray; N Beaudoin
Journal:  J Pharm Sci       Date:  1977-12       Impact factor: 3.534

2.  A simple method for determining acetylator phenotype using isoniazid.

Authors:  A Hutchings; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

3.  Effects of antacids on gastrointestinal absorption of isoniazid in rat and man.

Authors:  A Hurwitz; D L Schlozman
Journal:  Am Rev Respir Dis       Date:  1974-01

4.  Qualitative and quantitative drug-susceptibility tests in mycobacteriology.

Authors:  L Heifets
Journal:  Am Rev Respir Dis       Date:  1988-05

5.  No interaction between H2 blockers and isoniazid.

Authors:  O Paulsen; P Höglund; L G Nilsson; H Gredeby
Journal:  Eur J Respir Dis       Date:  1986-04

6.  Malabsorption of antimycobacterial medications.

Authors:  C A Peloquin; A A MacPhee; S E Berning
Journal:  N Engl J Med       Date:  1993-10-07       Impact factor: 91.245

7.  High-performance liquid chromatographic analysis of isoniazid and acetylisoniazid in biological fluids.

Authors:  A Hutchings; R D Monie; B Spragg; P A Routledge
Journal:  J Chromatogr       Date:  1983-10-14

8.  Influence of various diets on the bioavailability of isoniazid.

Authors:  P Männisto; R Mäntylä; E Klinge; S Nykänen; A Koponen; U Lamminsivu
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

9.  A method to prevent the loss of isoniazid and acetylisoniazid in human plasma.

Authors:  A Hutchings; R D Monie; B Spragg; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

10.  Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.

Authors:  C A Knupp; W C Shyu; R Dolin; F T Valentine; C McLaren; R R Martin; K A Pittman; R H Barbhaiya
Journal:  Clin Pharmacol Ther       Date:  1991-05       Impact factor: 6.875
View more
  4 in total

Review 1.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 2.  Drug interactions with antiviral drugs.

Authors:  A M Taburet; E Singlas
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

3.  Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.

Authors:  D P Healy; M C Brodbeck; C E Clendening
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Effect of bismuth subsalicylate on ciprofloxacin bioavailability.

Authors:  L Rambout; J Sahai; K Gallicano; L Oliveras; G Garber
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.